Instil Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Instil Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
  • Instil Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$530K, a 48.3% increase year-over-year.
  • Instil Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.78M, a 311% decline year-over-year.
  • Instil Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$575K, a 1.95% decline from 2022.
  • Instil Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$564K, a 55.8% increase from 2021.
  • Instil Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.28M, a 67.7% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.78M -$530K +$496K +48.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$2.28M -$702K -$1.33M -212% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$946K -$428K -$371K -651% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$575K -$120K -$1.42M -109% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $844K -$1.03M -$611K -147% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.46M $628K +$1.66M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$205K -$57K +$359K +86.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$564K $1.3M +$1.88M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$2.44M -$415K +$246K +37.2% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-13
Q2 2022 -$2.69M -$1.03M -$928K -892% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.76M -$416K -$487K -686% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$1.28M -$581K -$1.02M -231% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$251K -$661K -$1.11M -247% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $859K -$104K +$4.51M +97.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$3.65M $71K +$297K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$3.94M $443K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $449K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$4.61M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$226K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.